Schedule 13G ownership disclosure

PROGENICS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 734187106

Event date: 2014-07-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-14-004102
Form type
SC 13G/A
Filer
Broadfin Capital, LLC
CIK
CIK 1511901
Filed
Jul 21, 2014
Reporting period
Jul 15, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub